Head-to-head · WeighScore
DrBrainRx vs HumeCare+
By GLP-1 ScorecardUpdated
Score comparison
DrBrainRx has the higher recorded score — 70.8/100 to 58.6/100.
DrBrainRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DrBrainRx is a neurologist-founded telehealth clinic led by Dr. Sara Siavoshi (triple board-certified in Neurology, Headache Medicine, and Obesity Medicine) offering compounded semaglutide and tirzepatide injections through USP-certified 503B pharmacies.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | DrBrainRx | HumeCare+ |
|---|---|---|
| WeighScore | 70.8/100 | 58.6/100 |
| Grade | C | C |
| Site position | #111 | #328 |
| Semaglutide | $199/mo (all doses, compounded) | $199/mo (a floor, not a price: plus a separate fee at enrollment and every refill, non-refundable and never published; no dose stated, compounded) |
| Tirzepatide | $299/mo (all doses, compounded) | $299/mo (visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #111 · C
Strengths
- Founded and overseen by Dr. Sara Siavoshi — triple board-certified in Neurology, Headache Medicine, and Obesity Medicine
- LegitScript certified with compounded medications from USP-certified 503B pharmacies
- Flat-rate pricing — same monthly cost for all dose levels (dose escalation does not raise price)
- 100% online with rapid approvals (~24-48 hours) and discreet shipping in 3–5 business days
- Side-effect support, dose adjustments, and injection guides included with provider care
What to consider
- Separate $25/month provider care fee (compounded track) on top of medication cost
- Compounded medications are not FDA-approved individual drugs
- Labs not required or included — no baseline bloodwork protocol disclosed
- States served not published; no explicit list available
- No dedicated coaching program beyond clinical dose management
Site position #328 · C
Strengths
- Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
- Includes a Hume Pod body-composition device at no extra cost
- Billed monthly with no minimum term — the plan renews month to month and can be canceled before the renewal date, in a category full of three- and six-month prepays
- Backed by Hume Health, an established body-composition scale brand
- Clinician-prescribed and monitored with weekly tracking
What to consider
- The advertised $199 is a floor rather than the price: its terms charge a non-refundable clinical consultation fee at enrollment AND at every refill, never state what that fee is, and add that dosages or formulations may carry further charges at the company's sole discretion
- Final medication pricing is gated behind an intake quiz
- Only semaglutide is shown on the marketing site (tirzepatide not confirmed)
- Prescribing medical group and pharmacy partner not named
- States of operation not published
- LegitScript certification was not documented on the public pages reviewed
Featured provider
HumeCare+
HumeCare+ scores 58.6/100 (C). HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.